Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Si Sun

Showing results (121-130 of 400) with videos related to

Pageof 40
Sort By:
Cardiology|March 9, 2026
Efficacy of Remote Management in Chronic Heart Failure: A Prospective Cohort Study in Eastern ChinaYifan Yao, Yucheng Wu, Si Sun, et al.
Frontiers in Oncology|April 5, 2021
NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast CancerZhiyu Li, Bingxiong Liu, Chenyuan Li, et al.
Organic Letters|February 8, 2018
Construction of Benzene Rings by Copper-Catalyzed Cycloaddition Reactions of Oximes and Maleimides: An Access to Fused PhthalimidesJie Yang, Bo Zhao, Yue Xi, et al.
Peerj|May 22, 2020
EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancerSi Sun, Qiang Yang, E Cai, et al.
Cancer Cell International|December 8, 2018
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2<sup>Q607R</sup>Ying Zhang, Kuanyu Wang, Zheng Zhao, et al.
Blood Purification|November 11, 2016
Prognostic Biomarkers at Discontinuation of Renal Replacement Therapy in Acute Kidney Injury Patients in the Intensive Care UnitTingting Yang, Yuliang Zhao, Qiang Liu, et al.
Translational Cancer Research|February 4, 2022
The risk of developing acute non-lymphocytic leukemia in women with breast cancerZhong Wang, Zhiyu Li, Qi Wu, et al.
World Journal of Surgical Oncology|August 22, 2022
Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancerYuhui Huang, Lei Chen, Jing Cai, et al.
The Oncologist|April 5, 2022
Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II StudyZhihuang Hu, Si Sun, Xinmin Zhao, et al.
Frontiers in Molecular Biosciences|February 14, 2022
Metastatic Immune-Related Genes for Affecting Prognosis and Immune Response in Renal Clear Cell CarcinomaSi Sun, Weipu Mao, Lilin Wan, et al.
Pageof 40

Showing results (121-130 of 400) with videos related to

Sort By:
Pageof 40
Cardiology|March 9, 2026
Efficacy of Remote Management in Chronic Heart Failure: A Prospective Cohort Study in Eastern ChinaYifan Yao, Yucheng Wu, Si Sun, et al.
Frontiers in Oncology|April 5, 2021
NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast CancerZhiyu Li, Bingxiong Liu, Chenyuan Li, et al.
Organic Letters|February 8, 2018
Construction of Benzene Rings by Copper-Catalyzed Cycloaddition Reactions of Oximes and Maleimides: An Access to Fused PhthalimidesJie Yang, Bo Zhao, Yue Xi, et al.
Peerj|May 22, 2020
EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancerSi Sun, Qiang Yang, E Cai, et al.
Cancer Cell International|December 8, 2018
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2<sup>Q607R</sup>Ying Zhang, Kuanyu Wang, Zheng Zhao, et al.
Blood Purification|November 11, 2016
Prognostic Biomarkers at Discontinuation of Renal Replacement Therapy in Acute Kidney Injury Patients in the Intensive Care UnitTingting Yang, Yuliang Zhao, Qiang Liu, et al.
Translational Cancer Research|February 4, 2022
The risk of developing acute non-lymphocytic leukemia in women with breast cancerZhong Wang, Zhiyu Li, Qi Wu, et al.
World Journal of Surgical Oncology|August 22, 2022
Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancerYuhui Huang, Lei Chen, Jing Cai, et al.
The Oncologist|April 5, 2022
Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II StudyZhihuang Hu, Si Sun, Xinmin Zhao, et al.
Frontiers in Molecular Biosciences|February 14, 2022
Metastatic Immune-Related Genes for Affecting Prognosis and Immune Response in Renal Clear Cell CarcinomaSi Sun, Weipu Mao, Lilin Wan, et al.
Pageof 40